N
Nanobiotix
Paris, France
Founded 2003 Euronext: NANO
About
Clinical-stage biotechnology company pioneering nanomedicine with first-in-class radioenhancers for cancer treatment
Company Details
- Type
- commercial
- Employees
- 100-200
- Funding
- $200M+
Key Products
- NBTXR3 (Hensify)